共 297 条
[1]
Cohen JC(2006)Sequence variations in PCSK9, low LDL, and protection against coronary heart disease N Engl J Med 354 1264-72
[2]
Boerwinkle E(2012)Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis J Am Coll Cardiol 60 2631-9
[3]
Mosley TH(2004)Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 937-52
[4]
Hobbs HH(2011)Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials QJM 104 109-24
[5]
Ference BA(2005)Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267-78
[6]
Yoo W(2013)Statins for the primary prevention of cardiovascular disease Cochrane Database Syst Rev. 1 CD004816-94
[7]
Alesh I(2014)Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials J Am Coll Cardiol 64 485-67
[8]
Mahajan N(2013)2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult Can J Cardiol 29 151-818
[9]
Mirowska KK(2011)ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 1769-88
[10]
Mewada A(2014)National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary J Clin Lipidol 8 473-97